Tina M. Sauerwald, Ph.D.
Affiliations: | 2002 | Johns Hopkins University, Baltimore, MD |
Area:
Chemical Engineering, Molecular Biology, Biomedical EngineeringGoogle:
"Tina Sauerwald"Mean distance: 4190.84
Parents
Sign in to add mentor| Michael J. Betenbaugh | grad student | 2002 | Johns Hopkins | |
| (Engineering improved apoptosis inhibition in mammalian cell culture using modified proteins and multiple inhibitors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zustiak MP, Dorai H, Betenbaugh MJ, et al. (2012) Controlling apoptosis to optimize yields of proteins from mammalian cells. Methods in Molecular Biology (Clifton, N.J.). 801: 111-23 |
| Sauerwald TM, Figueroa B, Hardwick JM, et al. (2006) Combining caspase and mitochondrial dysfunction inhibitors of apoptosis to limit cell death in mammalian cell cultures. Biotechnology and Bioengineering. 94: 362-72 |
| Figueroa B, Sauerwald TM, Oyler GA, et al. (2003) A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures. Metabolic Engineering. 5: 230-45 |
| Sauerwald TM, Oyler GA, Betenbaugh MJ. (2003) Study of caspase inhibitors for limiting death in mammalian cell culture. Biotechnology and Bioengineering. 81: 329-40 |
| Sauerwald TM, Betenbaugh MJ, Oyler GA. (2002) Inhibiting apoptosis in mammalian cell culture using the caspase inhibitor XIAP and deletion mutants. Biotechnology and Bioengineering. 77: 704-16 |
| Betenbaugh M, Sauerwald T. (2002) Apoptosis in Biotechnology: Its Role in Mammalian Cell Culture and Methods of Inhibition Bioprocessing Journal. 1: 61-68 |
| Figueroa B, Sauerwald TM, Mastrangelo AJ, et al. (2001) Comparison of Bcl-2 to a Bcl-2 deletion mutant for mammalian cells exposed to culture insults. Biotechnology and Bioengineering. 73: 211-22 |